Cutaneous granulomatous vasculitis and extravascular granulomas

References

• Gibson LE, Winkelmann RK. Cutaneous granulomatous vasculitis: its relationship to systemic disease. J. Am. Acad. Dermatol.14(3), 492–501 (1986).
   PubMed Web of Science ®Google Scholar
• Finan MC, Winkelmann RK. The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine (Baltimore)62(3), 142–158 (1983).
   PubMed Web of Science ®Google Scholar
• Bloch DA, Michel BA, Hunder GG et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum.33(8), 1068–1073 (1990).
   PubMed Web of Science ®Google Scholar
• Fries JF, Hunder GG, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum.33(8), 1135–1136 (1990).
   PubMedGoogle Scholar
• Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum.33(8), 1065–1067 (1990).
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum.37(2), 187–192 (1994).
   PubMed Web of Science ®Google Scholar
• van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet1(8426), 425–429 (1985).
   PubMed Web of Science ®Google Scholar
• Savage CO, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet1(8547), 1389–1393 (1987).
   PubMed Web of Science ®Google Scholar
• Klinger H. Grenzformen der periarteritis nodosa. Frankfurter Zeitschrife für Pathologie42, 455–480 (1931).
   Google Scholar
• Pinching AJ, Lockwood CM, Pussell BA et al. Wegener’s granulomatosis: observations on 18 patients with severe renal disease. Q. J. Med.52(208), 435–460 (1983).
   PubMedGoogle Scholar
• Guillevin L, Cordier JF, Lhote F et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum.40(12), 2187–2198 (1997).
   PubMed Web of Science ®Google Scholar
• Walton EW. Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis). Br. Med. J.2, 265–270 (1958).
   PubMed Web of Science ®Google Scholar
• Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener’s granulomatosis. J. Rheumatol.30(1), 80–88 (2003).
   PubMedGoogle Scholar
• Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann. Intern. Med.98(1), 76–85 (1983).
   PubMed Web of Science ®Google Scholar
• Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann. Intern. Med.116(6), 488–498 (1992).
   PubMed Web of Science ®Google Scholar
• Lie JT. Wegener’s granulomatosis: histological documentation of common and uncommon manifestations in 216 patients. Vasa26(4), 261–270 (1997).
   PubMedGoogle Scholar
• Stone JH for the WGET study group. Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum.48(8), 2299–2309 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson G, Coles ET, Crane M et al. Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q. J. Med.83(302), 427–438 (1992).
   PubMedGoogle Scholar
• Reinhold-Keller E, Beuge N, Latza U et al. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum.43(5), 1021–1032 (2000).
   PubMed Web of Science ®Google Scholar
• Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin. Rheumatol.17(5), 364–368 (1998).
   PubMedGoogle Scholar
• Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann. Rheum. Dis.60(2), 170–172 (2001).
   PubMed Web of Science ®Google Scholar
• Nishino H, Rubino FA, Parisi JE. The spectrum of neurologic involvement in Wegener's granulomatosis. Neurology43(7), 1334–1337 (1993).
   PubMed Web of Science ®Google Scholar
• Reinhold-Keller E, de Groot K, Holl-Ulrich K et al. Severe CNS manifestations as the clinical hallmark in generalized Wegener’s granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature. Clin. Exp. Rheumatol.19(5), 541–549 (2001).
   PubMed Web of Science ®Google Scholar
• de Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold-Keller E. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch. Neurol.58(8), 1215–1221 (2001).
   PubMedGoogle Scholar
• Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum.33(8), 1101–1107 (1990).
   PubMed Web of Science ®Google Scholar
• Gibson LE, Specks U, Homburger H. Clinical utility of ANCA tests for the dermatologist. Int. J. Dermatol.42(11), 859–869 (2003).
   PubMedGoogle Scholar
• Francès C, Lê Thi Huong D, Piette JC et al. Wegener’s granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch. Dermatol.130(7), 861–867 (1994).
   PubMedGoogle Scholar
• Gibson LE. Granulomatous vasculitides and the skin. Dermatol. Clin.8(2), 335–345 (1990).
   PubMedGoogle Scholar
• Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stern JB, Travis WD. Cutaneous pathology in Wegener’s granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am. J. Surg. Pathol.19(2), 161–172 (1995).
   PubMedGoogle Scholar
• Hu CH, O’Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener granulomatosis. Arch. Dermatol.113(2), 175–182 (1977).
   PubMedGoogle Scholar
• Daoud MS, Gibson LE, DeRemee RA, Specks U, el-Azhary RA, Su WP. Cutaneous Wegener’s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J. Am. Acad. Dermatol.31(4), 605–612 (1994).
   PubMed Web of Science ®Google Scholar
• Bligny D, Mahr A, Le Toumelin P, Mouthon L, Guillevin L. Predicting mortality in systemic Wegener’s granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum.51(1), 83–91 (2004).
   PubMed Web of Science ®Google Scholar
• Churg J, Strauss L. Allergic angiitis and periarteritis nodosa. Am. J. Pathol.27, 277–301 (1951).
   PubMed Web of Science ®Google Scholar
• Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus7(4), 238–258 (1998).
   PubMed Web of Science ®Google Scholar
• Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum.51(1), 92–99 (2004).
   PubMed Web of Science ®Google Scholar
• Guillevin L, Guittard T, Blétry O, Godeau P, Rosenthal P. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung165(3), 165–1172 (1987).
   PubMedGoogle Scholar
• Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum.37(12), 1798–1803 (1994).
   PubMed Web of Science ®Google Scholar
• Chumbley LC, Harrison EG Jr, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo. Clin. Proc.52(8), 477–484 (1977).
   PubMed Web of Science ®Google Scholar
• Haas C, Le Jeunne C, Choubrac P, Durand H, Hugues FC. Churg-Strauss syndrome. Retrospective study of 20 cases. Bull. Acad. Natl Méd.185(6), 1113–1130 (2001).
   PubMed Web of Science ®Google Scholar
• Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78(1), 26–37 (1999).
   PubMed Web of Science ®Google Scholar
• Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore)63(2), 65–81 (1984).
   PubMed Web of Science ®Google Scholar
• Solans R, Bosch JA, Perez-Bocanegra C et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford)40(7), 763–771 (2001).
   PubMed Web of Science ®Google Scholar
• Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo. Clin. Proc.70(4), 337–341 (1995).
   PubMedGoogle Scholar
• Hattori N, Ichimura M, Nagamatsu M et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain122(Pt 3), 427–439 (1999).
   PubMed Web of Science ®Google Scholar
• Hellemans S, Dens J, Knockaert D. Coronary involvement in the Churg-Strauss syndrome. Heart77(6), 576–578 (1997).
   PubMed Web of Science ®Google Scholar
• Lanham JG, Cooke S, Davies J, Hughes GR. Endomyocardial complications of the Churg-Strauss syndrome. Postgrad. Med. J.61(714), 341–344 (1985).
   PubMed Web of Science ®Google Scholar
• Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore)84(2), 115–128 (2005).
   PubMed Web of Science ®Google Scholar
• Gaskin G, Clutterbuck EJ, Pusey CD. Renal disease in the Churg-Strauss syndrome. Diagnosis, management and outcome. Contrib. Nephrol.94, 58–65 (1991).
   PubMedGoogle Scholar
• Sablé-Fourtassou R, Cohen P, Mahr A et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann. Intern. Med.143(9), 632–638 (2005).
   PubMed Web of Science ®Google Scholar
• Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum.52(9), 2926–2935 (2005).
   PubMed Web of Science ®Google Scholar
• Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum.33(8), 1094–1100 (1990).
   PubMed Web of Science ®Google Scholar
• Davis MD, Daoud MS, McEvoy MT, Su WP. Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation. J. Am. Acad. Dermatol.37(2 Pt 1), 199–203 (1997).
   PubMedGoogle Scholar
• Dummer W, Zillikens D, Schulz A, Brocker EB, Hamm H. Scalp necrosis in temporal (giant cell) arteritis: implications for the dermatologic surgeon. Clin. Exp. Dermatol.21(2), 154–158 (1996).
   PubMedGoogle Scholar
• Baum EW, Sams WM Jr, Payne RR. Giant cell arteritis: a systemic disease with rare cutaneous manifestations. J. Am. Acad. Dermatol.6(6), 1081–1088 (1982).
   PubMedGoogle Scholar
• Small P, Brisson ML. Wegener’s granulomatosis presenting as temporal arteritis. Arthritis Rheum.34(2), 220–223 (1991).
   PubMedGoogle Scholar
• Hamidou MA, Moreau A, Toquet C, El Kouri D, de Faucal P, Grolleau JY. Temporal arteritis associated with systemic necrotizing vasculitis. J. Rheumatol.30(10), 2165–2169 (2003).
   PubMed Web of Science ®Google Scholar
• Nishino H, DeRemee RA, Rubino FA, Parisi JE. Wegener’s granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo. Clin. Proc.68(2), 115–121 (1993).
   PubMed Web of Science ®Google Scholar
• Palaic M, Yeadon C, Moore S, Cashman N. Wegener’s granulomatosis mimicking temporal arteritis. Neurology41(10), 1694–1695 (1991).
   PubMedGoogle Scholar
• Francès C, Boisnic S, Blétry O et al. Cutaneous manifestations of Takayasu arteritis. A retrospective study of 80 cases. Dermatologica181(4), 266–272 (1990).
   PubMedGoogle Scholar
• Pascual-Lopez M, Hernandez-Nunez A, Aragues-Montanes M, Dauden E, Fraga J, Garcia-Diez A. Takayasu’s disease with cutaneous involvement. Dermatology208(1), 10–15 (2004).
   PubMedGoogle Scholar
• Crotty CP, DeRemee RA, Winkelmann RK. Cutaneous clinicopathologic correlation of allergic granulomatosis. J. Am. Acad. Dermatol.5(5), 571–581 (1981).
   PubMedGoogle Scholar
• Wilmoth GJ, Perniciaro C. Cutaneous extravascular necrotizing granuloma (Winkelmann granuloma): confirmation of the association with systemic disease. J. Am. Acad. Dermatol.34(5 Pt 1), 753–759 (1996).
   PubMed Web of Science ®Google Scholar
• Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch. Dermatol.130(10), 1278–1283 (1994).
   PubMed Web of Science ®Google Scholar
• Obermoser G, Zelger B, Zangerle R, Sepp N. Extravascular necrotizing palisaded granulomas as the presenting skin sign of systemic lupus erythematosus. Br. J. Dermatol.147(2), 371–374 (2002).
   PubMed Web of Science ®Google Scholar
• Perrin C, Lacour JP, Castanet J, Michiels JF. Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis. Am. J. Dermatopathol.23(4), 295–298 (2001).
   PubMed Web of Science ®Google Scholar
• Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am. J. Dermatopathol.27(6), 504–528 (2005).
   PubMed Web of Science ®Google Scholar
• Lee MW, Jang KA, Lim YS et al. Cutaneous extravascular necrotizing granuloma (Churg Strauss granuloma). Clin. Exp. Dermatol.24(3), 193–195 (1999).
   PubMedGoogle Scholar
• Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum. Pathol.3(4), 457–558 (1972).
   PubMed Web of Science ®Google Scholar
• Dutz JP, Benoit L, Wang X et al. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 97(1), 95–100 (2001).
   PubMed Web of Science ®Google Scholar
• Beaty MW, Toro J, Sorbara L et al. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am. J. Surg. Pathol.25(9), 1111–1120 (2001).
   PubMed Web of Science ®Google Scholar
• Patton WF, Lynch JP III. Lymphomatoid granulomatosis. Clinicopathologic study of four cases and literature review. Medicine (Baltimore)61(1), 1–12 (1982).
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer43(1), 360–373 (1979).
   PubMed Web of Science ®Google Scholar
• Carlson KC, Gibson LE. Cutaneous signs of lymphomatoid granulomatosis. Arch. Dermatol.127(11), 1693–1698 (1991).
   PubMedGoogle Scholar
• James WD, Odom RB, Katzenstein AL. Cutaneous manifestations of lymphomatoid granulomatosis. Report of 44 cases and a review of the literature. Arch. Dermatol.117(4), 196–202 (1981).
   PubMedGoogle Scholar
• Scarabello A, Leinweber B, Ardigo M et al. Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas. Am. J. Surg. Pathol.26(10), 1259–1268 (2002).
   PubMed Web of Science ®Google Scholar
• Gibson LE, el-Azhary RA, Smith TF, Reda AM. The spectrum of cutaneous granulomatous vasculitis: histopathologic report of eight cases with clinical correlation. J. Cutan. Pathol.21(5), 437–445 (1994).
   PubMedGoogle Scholar
• Wooten MD, Jasin HE. Vasculitis and lymphoproliferative diseases. SeminArthritis Rheum.26(2), 564–574 (1996).
   Google Scholar
• Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J. Cutan. Pathol.30(1), 1–10 (2003).
   PubMed Web of Science ®Google Scholar
• Stern WK. Cutaneous rheumatoid vasculitis. Int. J. Dermatol.18(5), 394–397 (1979).
   PubMedGoogle Scholar
• Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P. The spectrum of cutaneous manifestations in lupus erythematosus – the Italian experience. Lupus9(6), 417–423 (2000).
   PubMed Web of Science ®Google Scholar
• Takemura T, Shishiba T, Akiyama O, Oritsu M, Matsui Y, Eishi Y. Vascular involvement in cutaneous sarcoidosis. Pathol. Int.47(2–3), 84–89 (1997).
   PubMedGoogle Scholar
• Zlatanic J, Fleisher M, Sasson M, Kim P, Korelitz BI. Crohn’s disease and acute leukocytoclastic vasculitis of skin. Am. J. Gastroenterol.91(11), 2410–2413 (1996).
   PubMedGoogle Scholar
• Chalvardjian A, Nethercott JR. Cutaneous granulomatous vasculitis associated with Crohn’s disease. Cutis30(5), 645–655 (1982).
   PubMedGoogle Scholar
• Snow JL, el-Azhary RA, Gibson LE, Estes SA, Espy MJ, Smith TF. Granulomatous vasculitis associated with herpes virus: a persistent, painful, postherpetic papular eruption. Mayo. Clin. Proc.72(9), 851–853 (1997).
   PubMedGoogle Scholar
• Rodriguez-Pereira C, Suarez-Penaranda JM, del Rio E, Forteza-Vila J. Cutaneous granulomatous vasculitis after herpes zoster infection showing polyarteritis nodosa-like features. Clin. Exp. Dermatol.22(6), 274–276 (1997).
   PubMedGoogle Scholar
• Crowson AN, Nuovo G, Ferri C, Magro CM. The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum. Pathol.34(6), 573–579 (2003).
   PubMed Web of Science ®Google Scholar
• Mendez P, Saeian K, Reddy KR et al. Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations. Am. J. Gastroenterol.96(8), 2489–2493 (2001).
   PubMedGoogle Scholar
• Rieu V, Cohen P, Andre MH et al. Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford)41(3), 290–300 (2002).
   PubMed Web of Science ®Google Scholar
• Jayne D. How to induce remission in primary systemic vasculitis. Best. Pract. Res.Clin. Rheumatol.19(2), 293–305 (2005).
   Google Scholar
• Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest.110(7), 955–963 (2002).
   PubMed Web of Science ®Google Scholar
• Pfister H, Ollert M, Frohlich LF et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood104(5), 1411–1418 (2004).
   PubMed Web of Science ®Google Scholar
• Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum.49, 93–100 (2003).
   PubMed Web of Science ®Google Scholar
• De Groot K, Rasmussen N, Bacon PA et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum.52(8), 2461–2469 (2005).
   PubMed Web of Science ®Google Scholar
• Jayne D, Rasmussen N, Andrassy K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N. Engl. J. Med.349(1), 36–44 (2003).
   PubMed Web of Science ®Google Scholar
• Fauci AS, Wolff SM. Wegener’s granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore)52(6), 535–561 (1973).
   PubMed Web of Science ®Google Scholar
• Stone JH for the WGET study group. Etanercept plus standard therapy for Wegener’s granulomatosis. N. Engl. J. Med. 352(4), 351–361 (2005).
   PubMedGoogle Scholar
• Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener’s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum.44(12), 2836–2840 (2001).
   PubMed Web of Science ®Google Scholar
• Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory wegener’s granulomatosis: report of a prospective, open-label pilot trial. Am. J. Respir. Crit. Care Med. (2005).
   PubMedGoogle Scholar
• Pagnoux C, Guillevin L. How can patient care be improved beyond medical treatment? Best. Pract. Res.Clin. Rheumatol.19(2), 337–344 (2005).
   Google Scholar